药品批准更新
Pharmaceutical Approval Update.
作者信息
Kaufman Michele B
出版信息
P T. 2019 Jan;44(2):42-44.
Abstract
Arikayce (amikacin liposome inhalation suspension) for complex lung disease; Xofluza (baloxavir marboxil) for acute uncomplicated influenza; and Nuzyra (omadacycline) for community-acquired bacterial pneumonia and/or acute bacterial skin and skin structure infections.
摘要
用于治疗复杂性肺部疾病的艾瑞凯思（阿米卡星脂质体吸入混悬液）；用于治疗急性非复杂性流感的Xofluza（巴洛沙韦马波西酯）；以及用于治疗社区获得性细菌性肺炎和/或急性细菌性皮肤及皮肤结构感染的Nuzyra（奥玛环素）。
相似文献
1
Pharmaceutical Approval Update.药品批准更新
P T. 2019 Jan;44(2):42-44.
2
Amikacin Liposome Inhalation Suspension: A Review in Mycobacterium avium Complex Lung Disease.硫酸卷曲霉素脂质体吸入混悬液治疗鸟分枝杆菌复合体肺病的研究进展
Drugs. 2019 Apr;79(5):555-562. doi: 10.1007/s40265-019-01095-z.
3
4
Amikacin Liposome Inhalation Suspension as a Treatment Option for Refractory Nontuberculous Mycobacterial Lung Disease Caused by Mycobacterium avium Complex.阿米卡星脂质体吸入混悬液作为鸟分枝杆菌复合体引起的难治性非结核分枝杆菌肺病的一种治疗选择。
Mayo Clin Proc. 2020 Jan;95(1):201-202. doi: 10.1016/j.mayocp.2019.10.024.
5
In reply-Amikacin Liposome Inhalation Suspension as a Treatment Option for Refractory Nontuberculous Mycobacterial Lung Disease Caused by Mycobacterium avium Complex.回复——阿米卡星脂质体吸入混悬液作为鸟分枝杆菌复合群引起的难治性非结核分枝杆菌肺病的一种治疗选择
Mayo Clin Proc. 2020 Jan;95(1):202. doi: 10.1016/j.mayocp.2019.10.023.
6
Combination treatment with the cap-dependent endonuclease inhibitor baloxavir marboxil and a neuraminidase inhibitor in a mouse model of influenza A virus infection.在甲型流感病毒感染的小鼠模型中，使用帽依赖性内切酶抑制剂巴洛沙韦马波西利和神经氨酸酶抑制剂进行联合治疗。
J Antimicrob Chemother. 2019 Mar 1;74(3):654-662. doi: 10.1093/jac/dky462.
7
Amikacin Liposome Inhalation Suspension for Treatment-Refractory Lung Disease Caused by Complex (CONVERT). A Prospective, Open-Label, Randomized Study.卷曲霉素脂质体吸入混悬液治疗复杂（CONVERT）引起的治疗抵抗性肺病。一项前瞻性、开放标签、随机研究。
Am J Respir Crit Care Med. 2018 Dec 15;198(12):1559-1569. doi: 10.1164/rccm.201807-1318OC.
8
Correction to: Amikacin Liposome Inhalation Suspension: A Review in Mycobacterium avium Complex Lung Disease.对《阿米卡星脂质体吸入混悬液：鸟分枝杆菌复合群肺病综述》的更正
Drugs. 2019 May;79(7):791. doi: 10.1007/s40265-019-01111-2.
9
Baloxavir marboxil: a novel cap-dependent endonuclease (CEN) inhibitor for the treatment of acute uncomplicated influenza.巴洛沙韦酯：一种用于治疗急性非复杂性流感的新型帽依赖性核酸内切酶（CEN）抑制剂。
Drugs Today (Barc). 2019 Jun;55(6):359-366. doi: 10.1358/dot.2019.55.6.2999889.
10
Omadacycline (Nuzyra)--a new tetracycline antibiotic.奥马环素（纽泽拉）——一种新型四环素类抗生素。
Med Lett Drugs Ther. 2019 May 20;61(1572):74-77.
引用本文的文献
1
Protein Disulfide Isomerase A3 Regulates Influenza Neuraminidase Activity and Influenza Burden in the Lung.蛋白二硫键异构酶 A3 调控流感神经氨酸酶活性和肺部流感病毒载量。
Int J Mol Sci. 2022 Jan 19;23(3):1078. doi: 10.3390/ijms23031078.
Zotero 插件